(19)
(11) EP 4 577 542 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23758664.9

(22) Date of filing: 24.08.2023
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/437(2006.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; A61P 35/00
(86) International application number:
PCT/EP2023/073233
(87) International publication number:
WO 2024/042163 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2022 EP 22306262

(71) Applicant: Sanofi
75017 Paris (FR)

(72) Inventors:
  • BERNARDELLI, Patrick
    75017 Paris (FR)
  • EL-AHMAD, Youssef
    75017 Paris (FR)
  • TERRIER, Corinne
    75017 Paris (FR)

(74) Representative: Ipsilon NNY 
11 rue Saint-Georges
75009 Paris
75009 Paris (FR)

   


(54) NOVEL SUBSTITUTED 2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE CARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF